Fennec prices $35M public offering of 4.7M shares at $7.50/share to repay debt

FENNEC PHARMACEUTICALS INC.

Offering of 4,666,667 common shares at $7.50 per share; gross proceeds ~$35M.
Underwriters granted 30-day option to purchase up to 700,000 additional shares.
Net proceeds to repurchase and redeem certain indebtedness and for working capital.
Closing expected November 17, 2025, subject to customary conditions.
Joint book-running managers: Piper Sandler & Co. and Craig-Hallum Capital Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.